JLK, Inc. (322510.KQ)

KRW 8660.0

(3.34%)

Market Cap (In KRW)

218.2 Billion

Revenue (In KRW)

2.48 Billion

Net Income (In KRW)

-7.32 Billion

Avg. Volume

668.32 Thousand

Currency
KRW
Country
Open
-
Prev. Close
-
Day Range
-
Year Range
6340.0-20750.0
PE
-
EPS
-
Beta Value
1.384
ISIN
-
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Industry
CEO
Mr. Dongmin Kim
Employee Count
-
Website
https://www.jlkgroup.com
Ipo Date
2019-12-11
Details
JLK, Inc. provides diagnosis support to the patients with it AI-driven solutions in South Korea. The company offers AI medical and AI security solutions. Its AI platform provides the on-site/real-time service that is connected to various systems built in the hospital and enables the professional needs of physicians to diagnose diseases. The company provides medical management, medical treatment, and medical service in brain diseases, such as ischemic stroke, hemorrhagic stroke, brain aneurysm, and Alzheimer's disease; and in lung diseases, coronary artery disease, prostate cancer, and digital pathology. The company was formerly known as JLK INSPECTION Co.,Ltd. JLK, Inc. is headquartered in Cheongju, South Korea.